Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date

Bassiony S, Harrison CN, McLornan DP

Therapeutics and Clinical Risk Management 2020, 16:889-901

Published Date: 25 September 2020